The Patent Finder

P2D Inc.

Also on record
Records under this name other than patents P2D Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to P2D Inc.

PatentTitleStatus Expires Confidence
US 7,361,6674′,4″-substituted 3α-(diphenylmethoxy) tropane analogs for treatment of mental disorders
Term ended
Term ended Mar 1, 2025 · From the USPTO record
Term endedTerm ended Mar 1, 2025From the USPTO record
US 8,546,430Thalidomide analogs
Term ended
Term ended Sep 17, 2024 · From the USPTO record
Term endedTerm ended Sep 17, 2024From the USPTO record
US 7,973,057Thalidomide Analogs
Lapsed on the fee record
Ended Jul 5, 2023 · High confidence
Lapsed on the fee recordEnded Jul 5, 2023High confidence
US 8,853,253Thalidomide analogs
Lapsed on the fee record
Ended Oct 7, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited